National Cancer Institute   Cancer Therapy Evaluation Program   Developing Cancer Therapies
CTEP HomeContactHelpSearch:

Investigator's Handbook
A Manual for Participants in Clinical Trials of Investigational Agents Sponsored by DCTD, NCI
Table of
Contents
Part A
1 2 3
Part B
4 5 6
Part C
7 8 9 10 11
Part D
12 13 14 15 16
Part E
17 18 19
Appendices

Part A: Sponsors, Research Bases, and the Investigator

1. Introduction

When investigators perform clinical trials, two organizations are crucial--the sponsor of the trial and the research base. The next two sections discuss the purposes and features of each. In particular, we describe the role of the DCTD as a sponsor of investigational agent trials; as a sponsor DCTD is responsible for the overall direction of the process of new agent development as well as its practical implementation. Of course, DCTD is not the only sponsor of trials involving new anticancer agents. The activity of private pharmaceutical companies has increased dramatically in recent years. We outline here the basis of the relationship among DCTD, pharmaceutical companies, and investigators supported by DCTD in the conduct of clinical trials. We also discuss the vital role of the research base in support of the investigator. As is the case with all types of research, clinical trials cannot take place without a substantial institutional commitment.

2. The Sponsor

3. The Research Base and the Investigator


  Home   |   Contact   |   Privacy Notice   |   Accessibility National Cancer Institute   National Institutes of Health   Department of Health and Human Services   USA.gov